Little or no excess risk of death, MI, stroke for those with five risk-factor variables within target ranges
FRIDAY, Aug. 17, 2018 (HealthDay News) — Little excess risk of death is seen for patients with type 2 diabetes with five risk-factor variables within target ranges, according to a study published in the Aug. 16 issue of the New England Journal of Medicine.
Aidin Rawshani, M.D., from the University of Gothenburg in Sweden, and colleagues conducted a cohort study involving 271,174 patients with type 2 diabetes and 1,355,870 matched controls. Patients with diabetes were assessed according to age categories and the presence of five risk factors.
Participants were followed for a median of 5.7 years, during which time there were 175,345 deaths. The researchers found that the excess risk of outcomes decreased stepwise for each risk-factor variable within the target range among patients with type 2 diabetes. For patients with diabetes with all five variables within target ranges, the hazard ratio for death from any cause was 1.06 (95 percent confidence interval, 1.00 to 1.12) compared with controls; the hazard ratios for acute myocardial infarction and stroke were 0.84 (95 percent confidence interval, 0.75 to 0.93) and 0.95 (95 percent confidence interval, 0.84 to 1.07), respectively.
“Patients with type 2 diabetes who had five risk-factor variables within the target ranges appeared to have little or no excess risk of death, myocardial infarction, or stroke, as compared with the general population,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis